Literature DB >> 8098819

Giant platelets in erucic acid therapy for adrenoleukodystrophy.

S Stöckler, B Molzer, B Plecko, W Zenz, W Muntean, U Söling, D H Hunneman, C Korenke, F Hanefeld.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8098819     DOI: 10.1016/0140-6736(93)90984-o

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.

Authors:  B M van Geel; J Assies; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

2.  Enhanced lymphocyte proliferation in patients with adrenoleukodystrophy treated with erucic acid (22:1)-rich triglycerides.

Authors:  R B Pour; S Stöckler-Ipsiroglu; D H Hunneman; M Gahr; G C Korenke; W Pabst; F Hanefeld; A Peters
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

3.  Platelets in treated adrenoleukodystrophy: a brief report.

Authors:  P Revell; A Green; S Green
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  Decreased platelet membrane anisotropy in patients with adrenoleukodystrophy treated with erucic acid (22:1)-rich triglycerides.

Authors:  S Stöckler; C Opper; A Greinacher; D H Hunneman; G C Korenke; C J Unkrig; F Hanefeld
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982

5.  Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: effect on clinical, biochemical and neurophysiological parameters.

Authors:  G C Korenke; D H Hunneman; J Kohler; S Stöckler; K Landmark; F Hanefeld
Journal:  Eur J Pediatr       Date:  1995-01       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.